Vaya
Bluelight Crew
Hey all,
It has recently come to my attention how utterly potent a 5HT2 antagonist risperidone really is; in another thread, I'd made the comment that 0.25mg was enough to nullify at least ninety percent of a 500ug LSD experience.
Desoxyn (dextro-methamphetamine HCl) is a fairly potent serotongergic (as well as DA/NE) agent, and I take 10mg Desoxyn and 0.25mg Risperdal (remember, enough to abort a 500ug psychedelic experience entirely) at precisely the same time each morning.
I am purely speculating, but would the fact that Risperdal is competing for control over the release of serotonin in my brain against dex-methamp nullify the serotonergic effect of Desoxyn? My line of inquiry stems from the fact that I do indeed feel the serotonergic effect of d-methamp when I take it, in addition to the obvious DA/NE effects, despite the fact that such a powerful 5HT2 antagonist (e.g. Risperdal) is being co-administered with it every morning.
I also know from an enlightened member of these lovely boards, that 5HT2 agonists are cross-tolerant with 5HT2 antagonists.
Would it therefore be an effective (or, dare I say it, reasonable) assumption to make that my response to the pharmacological mechanisms peculiar to each compound regarding serotonin are in-line to be greatly diminished, if not cancelled out by one another?
If my doctor spaced on her medical training the day she prescribed me Risperdal which not only antagonizes but creates a cross-tolerance with the powerful serotonergic DA/NE d-methamphetamine, would someone with a slightly (or entirely) more refined knowledge of neuropharmacology and psychiatry explain to me what, if any, potential dangers, side effects and/or long-term consequences I may be facing by routinely co-administering these compounds?
One example of a "long-term consequence" I have contrived in order to illustrate the type of speculation I need from you other members is as follows:
----------------------------------------------------------------------------------------------------------------------------------------------------------------------
Vaya, per doctors' orders, continues to co-administer the 5HT agonist d-methamp and 5HT antagonist risperdal for a period of time (for our purposes, let us say one year). Due to the aforementioned cross-tolerance, Vaya's beneficial reaction to the specific effects of each compound diminishes as time goes by, leaving him with an antipsychotic that does not antagonize as it should and a prescription stimulant that can no longer agonize as it should unless I were, God forbid, to increase the dosage that I am at already.
----------------------------------------------------------------------------------------------------------------------------------------------------------------------
I am eagerly anticipating even speculative answers on what may happen; I would, of course, address this issue with my M.D., but she happens to be on extended leave from her office right now and Advanced Drug Discussion has ubiquitously proven to be more invaluable in terms of real information than my M.D. has been in the past.
Bottom line: Am I set up for pharmacological failure right now?
Much obliged,
~ vaya
It has recently come to my attention how utterly potent a 5HT2 antagonist risperidone really is; in another thread, I'd made the comment that 0.25mg was enough to nullify at least ninety percent of a 500ug LSD experience.
Desoxyn (dextro-methamphetamine HCl) is a fairly potent serotongergic (as well as DA/NE) agent, and I take 10mg Desoxyn and 0.25mg Risperdal (remember, enough to abort a 500ug psychedelic experience entirely) at precisely the same time each morning.
I am purely speculating, but would the fact that Risperdal is competing for control over the release of serotonin in my brain against dex-methamp nullify the serotonergic effect of Desoxyn? My line of inquiry stems from the fact that I do indeed feel the serotonergic effect of d-methamp when I take it, in addition to the obvious DA/NE effects, despite the fact that such a powerful 5HT2 antagonist (e.g. Risperdal) is being co-administered with it every morning.
I also know from an enlightened member of these lovely boards, that 5HT2 agonists are cross-tolerant with 5HT2 antagonists.
Would it therefore be an effective (or, dare I say it, reasonable) assumption to make that my response to the pharmacological mechanisms peculiar to each compound regarding serotonin are in-line to be greatly diminished, if not cancelled out by one another?
If my doctor spaced on her medical training the day she prescribed me Risperdal which not only antagonizes but creates a cross-tolerance with the powerful serotonergic DA/NE d-methamphetamine, would someone with a slightly (or entirely) more refined knowledge of neuropharmacology and psychiatry explain to me what, if any, potential dangers, side effects and/or long-term consequences I may be facing by routinely co-administering these compounds?
One example of a "long-term consequence" I have contrived in order to illustrate the type of speculation I need from you other members is as follows:
----------------------------------------------------------------------------------------------------------------------------------------------------------------------
Vaya, per doctors' orders, continues to co-administer the 5HT agonist d-methamp and 5HT antagonist risperdal for a period of time (for our purposes, let us say one year). Due to the aforementioned cross-tolerance, Vaya's beneficial reaction to the specific effects of each compound diminishes as time goes by, leaving him with an antipsychotic that does not antagonize as it should and a prescription stimulant that can no longer agonize as it should unless I were, God forbid, to increase the dosage that I am at already.
----------------------------------------------------------------------------------------------------------------------------------------------------------------------
I am eagerly anticipating even speculative answers on what may happen; I would, of course, address this issue with my M.D., but she happens to be on extended leave from her office right now and Advanced Drug Discussion has ubiquitously proven to be more invaluable in terms of real information than my M.D. has been in the past.
Bottom line: Am I set up for pharmacological failure right now?
Much obliged,
~ vaya
Last edited:

